Monthly Treatment Costs: Mounjaro vs Ozempic UK
Understanding Your Monthly Investment
When comparing Ozempic and Mounjaro monthly costs, it's essential to understand these are different medications with distinct mechanisms and pricing structures. Mounjaro (tirzepatide) is a prescription-only injectable that activates both GIP and GLP-1 hormones, while Ozempic works through a single pathway. This dual-action approach may offer enhanced appetite regulation and improved feelings of fullness.
Mounjaro Monthly Cost Breakdown
Your monthly Mounjaro investment depends on your prescribed dose. Starting doses of 2.5mg cost £169.99 monthly, but new patients pay just £129.99 with our FIRST40 discount code. Maintenance doses range from £199.99 (5mg) to £318.99 (15mg), with first-order reductions of £40 and returning customer savings of £25 every month thereafter.
For dose escalation periods, our 2-pen bundles offer better value. The Intro Duo (2.5mg + 5mg) costs £339.99 normally but just £299.99 for new patients - covering your first two months with built-in progression planning.
Why Choose Mounjaro Over Alternatives
Mounjaro's dual-hormone mechanism may provide superior appetite control compared to single-action medications like Ozempic. Clinical studies support tirzepatide's effectiveness when used alongside reduced-calorie diets and increased physical activity. The prescription-only medication requires clinical assessment but offers potentially enhanced results for suitable patients.
Reducing Your Monthly Treatment Costs
Smart ordering strategies can significantly reduce your monthly spend. New patients save £40 immediately, reducing 2.5mg starter costs to just £129.99. Returning customers enjoy £25 monthly discounts - meaning your 2.5mg maintenance drops to £144.99 monthly. Bundle options provide additional savings during dose escalation phases.
Consider our 3-pen bundles for maximum value during titration periods. The Intro Trio covers three months of treatment progression for £574.99 (£534.99 new patients) - representing substantial savings versus individual pen purchases.
Express Assessment and Rapid Access
Standard clinical assessment takes 3 working days, ensuring thorough evaluation of your suitability for treatment. Express 24-hour approval is available as a paid upgrade for urgent treatment starts. Both options include comprehensive medical review by GPhC-registered prescribers.
Complete your clinical assessment today and secure your discounted first order. Monthly subscriptions ensure consistent treatment access with automatic returning customer discounts applied to every delivery.
